The eradication of Helicobacter pylori infection is still a challenge for clinicians. Approximately 5% of patients who undergo two courses of eradication therapy remain infected. The authors of this Viewpoint article discuss the available options for salvage therapy in these patients and the role of antimicrobial susceptibility testing in this setting.
What is the best salvage therapy for patients with Helicobacter pylori infection?
FUCCIO, LORENZO;ZAGARI, ROCCO MAURIZIO;BAZZOLI, FRANCO
2008
Abstract
The eradication of Helicobacter pylori infection is still a challenge for clinicians. Approximately 5% of patients who undergo two courses of eradication therapy remain infected. The authors of this Viewpoint article discuss the available options for salvage therapy in these patients and the role of antimicrobial susceptibility testing in this setting.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
